Multiply Labs

Multiply Labs is a robotics company based in San Francisco that focuses on automating the manufacturing of individualized, precision medicines for the life science and pharmaceutic

al industries, particularly in cell therapy production. The company offers a modular robotic system that integrates seamlessly with existing biomanufacturing instruments, providing closed-system GMP automation throughout the entire process. This allows scientists to supervise and innovate while robots handle tasks in cleanroom environments, facilitating industrial-scale production of gene-modified cell therapies and personalized drug dosages. The technology developed by Multiply Labs aims to reduce manufacturing bottlenecks and minimize human contamination, addressing significant cost challenges in advanced biologics. The company has secured a $20 million Series A funding round led by Casdin Capital, with participation from other notable investors. Multiply Labs collaborates with major organizations in pharmaceutical manufacturing, including Cytiva and Thermo Fisher Scientific, and works alongside partners like Y Combinator and MIT. Their mission is to make next-generation precision medicines accessible to all patients by enabling scalable production of life-saving therapies.